Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Queensland Health
Cantor Fitzgerald
Johnson and Johnson
Chinese Patent Office

Generated: January 24, 2018

DrugPatentWatch Database Preview

Details for Patent: 3,783,861

« Back to Dashboard

Summary for Patent: 3,783,861
Abstract:An instrument for the insertion into the uterus of a flexible contraceptive device formed from a tubular barrel having a first end for insertion into the uterus and an adjustable stop member for engaging the cervical is at a selected distance for the anterior end of the insertion end. The barrel has diametrically opposed axially extending apertures therein located posteriorly of the stop member for receiving the intrauterine device with the first arm thereof extending through the apertures transversely of the barrel and the second arm extending axially within the barrel toward the posterior portion thereof. A crossbar is provided on the barrel adjacent the apertures for folding the first arm into the barrel adjacent the second arm and substantially parallel thereto. A plunger member, telescopically inserted in the posterior portion of the barrel, has a free end adapted to move the folded intrauterine device from its position adjacent the apertures through the first barrel end to deposit the device in the uterus.
Inventor(s): Abramson; Harvey J. (New York, NY)
Assignee: G. D. Searle & Co. (Chicago, IL)
Application Number:05/152,101
Patent Claim Types:
see list of patent claims

Drugs Protected by US Patent 3,783,861

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
US Department of Justice
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.